4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-064256
Chief Scientific Officer sold 11,742 shares at an average $14.08 ($165,366)
- Chief Scientific Officer acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Michaelson Jennifer · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-20 | Sale : show line 1 in the form 10b5-1 | −3,742 | $13.62 | $50,966 | 181,977 | D |
| 2026-02-20 | Exercise or conversion : show line 2 in the form 10b5-1 | +8,000 | $4.30 | $34,400 | 189,977 | D |
| 2026-02-20 | Sale : show line 3 in the form 10b5-1 | −8,000 | $14.30 | $114,400 | 181,977 | D |
| Open-market sales · 11,742 sh · avg $14.08 · $165,366 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-20 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −8,000 | 124,987 | D |
Loading xslF345X05/ownership.xml…